Milestone Scientific's STA(TM) System Named By Dentistry Today as One of '2007 Top 100 Products'
LIVINGSTON, N.J., June 4 /PRNewswire/ -- Milestone Scientific, Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, announced today that it has been notified by Dentistry Today, the nation's leading clinical publication for dentists, that the Company's new Single Tooth Anesthesia (STA(TM)) System will be featured as one of Dentistry Today's "2007 Top 100 Products" in its upcoming July issue.
Leonard Osser, Chairman and CEO of Milestone Scientific, stated, "We are very pleased and honored that Dentistry Today has chosen to designate the STA System as one of the industry's best products of the year. This is a notable achievement for Milestone and a powerful endorsement of our innovative new technology that will advance the delivery of local anesthesia into the realm of technology adopted by the rest of dentistry."
The STA System with Dynamic Pressure Sensing (DPS(TM)) Technology is a patented, computer-controlled injection device that delivers predictable primary local anesthesia with immediate onset. It provides virtually painless delivery of all standard injections and allows the clinician to perform an STA-Intraligamentary (PDL) injection as the primary injection, replacing the Mandibular Block. Additionally, its' real-time, pressure-sensing audio/visual feedback ensures accuracy and safety and pencil-like handpiece enables precision. The System is comprised of a computer controlled drive unit and a single-use, disposable handpiece/needle assembly. For more information, contact Milestone Scientific at (877) STA-IS4U or visit STAIS4U.com.
About Milestone Scientific, Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2006. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief Strategist 407-585-1080 or via email at firstname.lastname@example.org
SOURCE Milestone Scientific, Inc.
Released June 4, 2007